tech
Netherlands expands investment screening to AI and biotech
The Netherlands will screen foreign investment in AI, biotech, and four other technology sectors from January 2027, affecting hundreds of companies. The move follows the Nexperia controversy and last month’s block of a US cloud acquisition.
TL;DR
- The Netherlands will add AI, advanced materials, nanotechnology, sensor and navigation technology, nuclear technology for medical use, and biotechnology to its investment screening regime.
- The new rules, effective from January 1, 2027, will require mandatory government review for foreign investors acquiring significant stakes in Dutch companies within these sectors.
- The expansion is a response to concerns about cyber operations, espionage, and sabotage, and follows the Nexperia acquisition controversy.
- The government recently blocked the acquisition of Solvinity by American firm Kyndryl, demonstrating the screening applies to allies as well as adversaries.
- The Netherlands is joining other European countries in tightening investment screening for AI and deep tech, reflecting the EU's focus on technology sovereignty.
- The expanded rules must undergo a parliamentary review before implementation.